Novavax Announces Management Promotion
October 01 2015 - 4:30PM
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
that Jody Lichaa has been named Vice President, Quality Assurance.
Ms. Lichaa joined Novavax as the Executive Director, Quality
Assurance in October 2011. She is responsible for providing
strategy, oversight, and direction of the Company’s quality
assurance.
Prior to joining Novavax, she was Senior
Director, Quality at PharmAthene from 2005 until 2011, where she
managed that company’s global QA/QC activities. Her prior
experience includes quality assurance positions of increasing
responsibility in a number of companies including Baxter, Shire and
BioReliance. Ms. Lichaa received her B.S. in Toxicology from
Northeastern University.
“Jody has successfully developed and managed a
talented quality assurance team that has been instrumental in the
ongoing development of our vaccine candidates,” said Stanley C.
Erck, President and CEO. “Jody’s talent and expertise will continue
to be critical as we prepare for Phase 3 development of our RSV F
Vaccines.”
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024